English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Int. J. Clin. Rheumatol. (2020) 15(6), 198-200 ISSN 1758-4272 Introduction Reactive arthritis belongs to a group of diseases called Spondyloarthropathies typically causing monoarthritis or oligoarthritis that usually involves the lower limbs (ankles and knees) as seen in our patient [1]. It usually takes 1-4 weeks for ReA (Reactive arthritis) to occur after an infection [2]. ReA is triggered by an extra-articular infection not present in the synovial fluid of the joint [1]. It occurs classically secondary to sexually transmitted or gastro intestinal infections. Common causative agents are Chlamydia Trichomatis, Shigella, Salmonella, Yersinia and Compylobacter species [3]. However, other viral infections may also cause ReA. A case of clinical ReA occurring after HIV infection was reported by Kishimoto, et al in 2006 [4]. A syndrome consistent with ReA has also been reported with Dengue, Chickungunya and Parvo virus B19 [5].

Post COVID-19 Reactive Arthritis: An Emerging Existence In The Spectrum Of Musculoskeletal Complications Of SARS-CoV-2 Infection